Millennium gets Corey chemistry | Chemical & Engineering News
Volume 82 Issue 23 | p. 12 | Concentrates
Issue Date: June 7, 2004

Millennium gets Corey chemistry

Department: Business

Millennium Pharmaceuticals has signed a research agreement with Harvard University and Harvard chemistry professor E. J. Corey. Under the deal, Harvard has granted Millennium rights to intellectual property for a family of proteasome inhibitors made with a chemical synthesis developed by Corey. Millennium will pay milestone fees and royalties to Harvard on sales of products resulting from the deal. Millennium won approval for the first proteasome-inhibiting drug, the blood cancer treatment Velcade (bortezomib), about a year ago.

Chemical & Engineering News
ISSN 0009-2347
Copyright © American Chemical Society

Leave A Comment

*Required to comment